Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Actress Sharon Stone Praises Barrow's New Leader

Barrow Neurological Institute
Posted on: 26 Oct 17

PHOENIX, Oct. 25, 2017 /PRNewswire/ -- Academy Award-nominated actress Sharon Stone today visited Barrow Neurological Institute to publicly welcome the Institute's new leader, Michael Lawton, MD.  Dr. Lawton, who succeeded Robert Spetzler, MD, as Barrow's President and CEO in June, was Stone's brain surgeon in San Francisco after she suffered a ruptured brain aneurysm in 2001. Stone credits Dr. Lawton with saving her life.

"I am proud to welcome to Barrow the man who saved my life," says Stone. "The majority of people who go through what happened to me do not survive, let alone recover. I'm able to be here today and walking and talking because of Dr. Lawton."

Dr. Lawton was recruited to Barrow after an extensive national search that considered many of the foremost names in neurosurgery.  He was previously at the University of California at San Francisco (UCSF) serving as vice chairman and chief of vascular neurosurgery in the Department of Neurological Surgery.

During a press conference at Barrow, Dr. Lawton announced plans to increase the Institute's faculty, expand its campus, and grow Barrow's prominence as the leading neurosciences institute in the United States.

"I'm thrilled to join Barrow as its new leader and I'm honored that Sharon took time out of her busy schedule to welcome me on behalf of the patients I've treated," said Dr. Lawton. "When I was deciding what to do in medicine, I wanted my work to have a profound effect on patients' lives and so I chose neurosurgery. When a patient thanks me for saving their life, there is no greater reward. When that patient is a Hollywood legend and American icon like Sharon, it doesn't get any better."

During Stone's visit, Dr. Lawton unveiled his vision for the Institute. "I come to Barrow with the promise of expanding the Institute's amazing accomplishments and legacy of bold innovation. The extraordinary team here will establish Barrow as the best neuroscience center in the world and will help patients like Sharon Stone make remarkable recoveries."

The new leader of Barrow outlined his three key initiatives including:  transforming Barrow's home with the addition of an innovative neuroscience workspace in the spirit of "Googleplex," launching the Barrow Artificial Intelligence Center, and establishing a major research program called the Barrow Aneurysm and AVM Research Center.

Dr. Lawton underscored that as Barrow grows its clinical and research programs, the Institute's physical footprint also will need to expand.  Barrow, which is located at Dignity Health St. Joseph's Hospital and Medical Center, is planning to construct a 5-story building on St. Joseph's campus that will capture the "creative energy of the neurosciences community."

The goal of this expansion is to bring to Barrow the "same excitement as Google's headquarters in Silicon Valley, where the most-talented neuroscientists, neurosurgeons, and neurologists in the world collaborate and collide, physically and mentally, to innovate and advance our field," he said.

Dr. Lawton heralded the new Barrow Artificial Intelligence Center, saying it will make the Institute a global leader in developing clinical tools for neuroscientists, as well as better outcomes and possible cost savings for patients.  The Institute has recruited one of the world's leading artificial intelligence medical experts to lead the center and transform the speed and accuracy of neurological diagnosis and treatment.

"Artificial Intelligence will change the practice of medicine in the next decade," says Dr. Lawton. "With our new supercomputer that is more powerful than IBM Watson, we now have resources that no other neuroscience institute in the nation has and we will be leading in this space."

The Barrow Aneurysm and AVM Center will study these two deadly causes of stroke.  Barrow is one of the busiest centers in the nation for treating these conditions and has a long history of clinical innovation in the management of these patients.  Four top scientists recruited from around the country will form the nucleus of this research team. 

"There's a dire need for increased research on brain aneurysms and other causes of bleeding in the brain," said Dr. Lawton.  "A brain aneurysm ruptures every 18 minutes in the U.S. and 40 percent of those ruptures are fatal. Two-thirds of survivors suffer permanent neurological deficits. The federal government currently only spends approximately 83 cents per year on brain aneurysm research for each person afflicted, which is simply not enough."

Dr. Lawton is no stranger to Barrow and Phoenix. Before taking the position at UCSF, he spent his seven year medical residency training at Barrow under his predecessor, Dr. Spetzler, who retired in June. While at UCSF, Dr. Lawton built a prominent cerebrovascular service and amassed a clinical experience in vascular neurosurgery unheard of for someone his age. He has treated more than 4,300 aneurysms, 800 brain arteriovenous malformations, and 1,000 cavernous malformations and is highly regarded by his peers around the globe for his surgical skills, patient care, innovation, and research efforts.

Barrow, which performs more brain surgeries annually than any hospital in the United States and is home to the Muhammad Ali Parkinson Center, has long been a world leader in health care and has treated thousands of patients from around the world. It is consistently ranked as a top hospital for neurology and neurosurgery by U.S. News & World Report.

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 26/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.